2-Aminopurine

2-Aminopurine

SCHEMBL5631

Nc1ncc2nc[nH]c2n1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
RXFP1 Q9HBX9 1/20 0.39
KDM4E B2RXH2 4/20 0.38
MAPT P10636 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
APEX1 P27695 1/20 0.38
RECQL P46063 1/20 0.38
BLM P54132 1/20 0.38
HPGD P15428 3/20 0.35
PDPK1 O15530 1/20 0.35
GDA Q9Y2T3 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PRKCI P41743 1/20 0.35
RAD52 P43351 1/20 0.34
CDK2 P24941 1/20 0.33
DPP4 P27487 1/20 0.33
GRM4 Q14833 1/20 0.33
TP53 P04637 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Aminopurine SCHEMBL29901502 1.00 ALDH1A1 (0.48) ALDH1A1RXFP1KDM4EMAPTTDP1
2-Aminopurine SCHEMBL28283405 0.98 ALDH1A1 (0.47) ALDH1A1RXFP1KDM4EMAPTTDP1
2-Aminopurine SCHEMBL1528157 0.91 ALDH1A1 (0.42) ALDH1A1RXFP1KDM4EMAPTTDP1
2-Aminopurine SCHEMBL10551243 0.91 ALDH1A1 (0.42) ALDH1A1RXFP1KDM4EMAPTTDP1
2-Aminopurine SCHEMBL383841 0.89 ALDH1A1 (0.41) ALDH1A1RXFP1KDM4EMAPTTDP1
2-Aminopurine SCHEMBL20305128 0.89 ALDH1A1 (0.41) ALDH1A1RXFP1KDM4EMAPTTDP1
2-Aminopurine SCHEMBL4342851 0.89 ALDH1A1 (0.41) ALDH1A1RXFP1KDM4EMAPTTDP1
2-Aminopurine SCHEMBL8343847 0.89 ALDH1A1 (0.41) ALDH1A1RXFP1KDM4EMAPTTDP1
2-Aminopurine SCHEMBL9014624 0.89 ALDH1A1 (0.41) ALDH1A1RXFP1KDM4EMAPTTDP1
2-Aminopurine SCHEMBL2787170 0.89 ALDH1A1 (0.41) ALDH1A1RXFP1KDM4EMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 28945 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144879-A1 ANTI-VIRAL AND HEPATIC-TARGETED DRUGS AI-BIOPHARMA (FR) 2026-05-28 US claimed
US-20260139030-A1 CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION SHATTUCK LABS INC (US) 2026-05-21 US claimed
WO-2026106497-A2 FUNCTIONALIZED CIRCULAR RNA AND METHODS AND INTERMEDIATES FOR THEIR PRODUCTION SIEĆ BADAWCZA ŁUKASIEWICZ – PORT POLSKI OSRODEK ROZWOJU TECHNOLOGII (PL) 2026-05-21 WO claimed
WO-2026106907-A1 FAST PCR BY TANDEM PRIMER EMBEDDED WITH RIBONUCLEOTIDE CEPHEID (US) 2026-05-21 WO claimed
WO-2026099316-A1 COMPOUNDS AND METHODS FOR REDUCING ARHGEF6 EXPRESSION ASTRAZENECA AB (SE) 2026-05-15 WO claimed
CN-122004239-A Durian flower forcing agent, preparation method and application 中国热带农业科学院热带作物品种资源研究所 2026-05-12 CN claimed
US-12618064-B2 Acetylated ribonucleic acids and uses thereof HELIX NANOTECHNOLOGIES INC (US) 2026-05-05 US claimed
US-20260117214-A1 Prime Editing Systems having pegRNA with Reduced Auto-inhibitory Interaction UNIV MASSACHUSETTS (US) 2026-04-30 US claimed
US-20260109977-A1 MODIFIED RNA FOR INCREASING PROTEIN EXPRESSION TRILINK BIOTECHNOLOGIES, LLC (US) 2026-04-23 US claimed
EP-4726042-A2 ANTISENSE OLIGOMERS TARGETING SETD5 FOR UPREGULATION AND USE THEREOF Korea Advanced Institute of Science and Technology (KR) 2026-04-15 EP claimed
EP-0358154-A2 Novel cyclobutane derivative and process for producing same NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1990-03-14 EP claimed
EP-0098122-B1 PROCESSES FOR PRODUCING L-PROLINE BY FERMENTATION KYOWA HAKKO KOGYO CO., LTD. (JP) 1989-05-31 EP claimed
EP-0309491-A1 ANTIVIRAL AGENTS SRI INTERNATIONAL (US) 1989-04-05 EP claimed
WO-1988005438-A1 ANTIVIRAL AGENTS SRI INTERNATIONAL (US) 1988-07-28 WO claimed
EP-0269947-A1 Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CS) 1988-06-08 EP claimed
CN-85106211-A Antistaling agent for cut-flower 1987-04-01 CN claimed
EP-0105360-A4 ANTIBODIES HAVING DUAL SPECIFICITIES, THEIR PREPARATION AND USES THEREFOR. HYBRITECH INC (US) 1986-07-08 EP claimed
EP-0105360-A1 ANTIBODIES HAVING DUAL SPECIFICITIES, THEIR PREPARATION AND USES THEREFOR HYBRITECH INCORPORATED (US) 1984-04-18 EP claimed
EP-0098122-A2 Processes for producing L-proline by fermentation KYOWA HAKKO KOGYO CO., LTD. (JP) 1984-01-11 EP claimed
WO-1983003679-A1 ANTIBODIES HAVING DUAL SPECIFICITIES, THEIR PREPARATION AND USES THEREFOR HYBRITECH INC (US) 1983-10-27 WO claimed